glp-1 receptor agonist antipsychotic weight gain study New Loss Drugs in Psychiatry GLP-1 Agonists For Obesity In
Description
So right now, aleniglipron is actually the only oral SM GLP-1RA with disclosed Phase 2b weight loss data in the same ballpark as orforgliprons ~12.4% at 36 mg/72 wks from ATTAIN-1, with Phase 3 planned mid-2026
Rather than taking a one-size-fits-all approach, a clinic like MTC can evaluate your medical history, discuss your wellness goals, and help determine if therapies like GLP-1 weight loss injections are a safe and appropriate fit for you
She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling
SGLT2i alone, while Guo et al
